LIB THERAPEUTICS AND SUN PHARMA ANNOUNCE GLOBAL LICENSING, COMMERCIALIZATION AND MANUFACTURING AGREEMENT FOR LERODALCIBEP, A NOVEL PCSK9 INHIBITOR, EX-US AND CHINA; LERODALCIBEP (LYROKAUL®) APPROVED IN THE EU

Reuters · 2d ago

Please log in to view news